The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes

This review examines the available literature on the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on renal outcomes in type 2 diabetes mellitus. Diabetes is an important cause of end-stage renal disease requiring renal replacement therapy, and diabetic kidney disease is an independ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Win L., Bain, Steve C., Min, Thinzar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136364/
https://www.ncbi.nlm.nih.gov/pubmed/32185624
http://dx.doi.org/10.1007/s13300-020-00798-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136364/
https://www.ncbi.nlm.nih.gov/pubmed/32185624
http://dx.doi.org/10.1007/s13300-020-00798-x

Ejemplares similares